Author

D. C. Bulmer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Assay:electrophysiology· 2

Frequent Co-Authors

E. S. J. Smith· 3 shared F. Welsh· 2 shared J. P. Higham· 2 shared J. R. Hockley· 2 shared K. H. Barker· 2 shared L. W. Paine· 2 shared A. J. Brown· 1 shared D. Sagnat· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPhysiology

E. S. J. Smith

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

TRPV4 stimulates colonic afferents through mucosal release of ATP and glutamate

M. Y. Meng, L. W. Paine, D. Sagnat, I. Bello, S. Oldroyd, F. Javid, M. T. Harper, J. R. Hockley, E. S. J. Smith, R. M. Owens, L. Alric, E. Buscail, F. Welsh, N. Vergnolle, D. C. Bulmer

This study shows TRPV4 activation in the colon increases afferent activity via mucosal release of ATP and glutamate, suggesting a target for visceral pain treatment.

bioRxiv · Apr 12, 2024Pharmacology & Toxicology

GPR35 inhibits TRPA1-mediated colonic afferent hypersensitivity through suppression of Substance P release

R. A. Gupta, J. P. Higham, P. Urriola-Munoz, K. H. Barker, L. W. Paine, J. Ghooraroo, J. R. Hockley, T. Rahman, E. S. J. Smith, A. J. Brown, R. Suzuki, D. C. Bulmer

This paper identifies GPR35 as a target for non-opioid analgesics by showing it inhibits TRPA1-mediated colonic hypersensitivity through suppression of Substance P release.

bioRxiv · Sep 12, 2023 · PreprintPhysiology

Sensitisation of colonic nociceptors by IL-13 is dependent on JAK and p38 MAPK activity

K. H. Barker, J. P. Higham, L. A. Pattison, I. P. Chessell, F. Welsh, E. S. J. Smith, D. C. Bulmer

This study shows IL-13 sensitizes colonic nociceptors via JAK and p38 MAPK signaling, offering therapeutic targets for visceral pain in gastrointestinal diseases.

bioRxiv · Oct 26, 2022 · PreprintPhysiology